Recursion Pharmaceuticals (RXRX) ended the recent trading session at $4.65, demonstrating a -4.12% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.26%.

Major iPhone updates like iOS 26 typically come with hundreds of new features and changes, but a much smaller subset that become daily go-tos. Here are four new iOS 26 features I’ve found myself using ...

Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with pseudo-inverse training implemented using JavaScript. Compared to other training techniques, such as ...

Wil Haygood’s “The War Within a War” is a rare, illuminating look at the way the war shaped the struggle for equality back home. By Brent Staples As usual, Lionel Shriver sets out to puncture pieties, ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Vikki Velasquez is a researcher and writer who has managed, coordinated, and directed various community and nonprofit organizations. She has conducted in-depth research on social and economic issues ...